Olympia Pharmaceuticals Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Olympia Pharmaceuticals's estimated annual revenue is currently $18.9M per year.(i)
  • Olympia Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Olympia Pharmaceuticals has 94 Employees.(i)
  • Olympia Pharmaceuticals grew their employee count by 38% last year.

Olympia Pharmaceuticals's People

NameTitleEmail/Phone
1
President /CEOReveal Email/Phone
2
Director PharmacyReveal Email/Phone
3
Brand DirectorReveal Email/Phone
4
Quality Systems ManagerReveal Email/Phone
5
Quality ManagerReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Senior Quality ManagerReveal Email/Phone
8
Human Resources ManagerReveal Email/Phone
9
Financial Controller & Sales ManagerReveal Email/Phone
10
PharmacistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is Olympia Pharmaceuticals?

At Olympia Pharmaceuticals, we understand the importance as well as the necessity of offering both 503A and 503B compounding pharmacy capabilities. Each of these designations of compounders plays a crucial role in filling today’s compounding landscape. With our two separate, state-of-the-art facilities, Olympia supports both patient-specific and office-use needs across the U.S., enabling our customers to comply with all national and state regulatory requirements while having the convenience of a single-source pharmacy partner.

keywords:N/A

N/A

Total Funding

94

Number of Employees

$18.9M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M946%N/A
#2
$7.5M94-1%N/A
#3
$25.4M946%N/A
#4
$31.4M9513%N/A
#5
$20.9M9544%N/A